About: Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1997 (uk) articolo scientifico (pubblicato il 1997) (it) article scientifique publié en 1997 (fr) im Januar 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1997 (ast) artikull shkencor i botuar më 01 janar 1997 (sq) scientific article published on 01 January 1997 (en)
publication date	wds:Q73016380-DFC05345-0DE7-431A-972E-9594720D38FB
publication date	1997-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73016380-4747BC97-DF68-4C46-B2FC-8305F1CDF788
language of work or name	English
cites work	wds:Q73016380-01A15222-389B-4DE0-8BED-C6D81630B6E8 wds:Q73016380-10FD5E23-2541-4837-B66F-49DD7B7224E6 wds:Q73016380-1D9FE28D-E7DF-4605-88F6-C3F25CEE8844 wds:Q73016380-2F8883D2-21BA-48C0-82BD-261AE293236A wds:Q73016380-2FD7B47B-A7E9-4FF9-8E11-31C3743B9A88 wds:Q73016380-4CEBAAB8-161A-48DF-B450-B8BA4B7F4D32 wds:Q73016380-6721FDE0-2F4C-4E64-A52E-474D685E6F17 wds:Q73016380-70DA6CE4-5DBD-4767-91E2-F138C231CD7B wds:Q73016380-815B8235-FCD3-47D0-9F69-B30D53362DDC wds:Q73016380-8A3EBF3C-AAC1-4E38-BDAB-3E37A4FDCDD1 wds:Q73016380-9285A629-E7A5-4247-82F5-6E2C1CC0F282 wds:Q73016380-96109E28-DED3-4740-8B4A-28BD36D9007D wds:Q73016380-AA7ED9BB-7F08-4DB9-BD9E-234B91C66C27 wds:Q73016380-C1B81EE6-22A5-49F1-AB21-C0D0061B47A3 wds:Q73016380-CA3C31F5-BFE9-4D0E-BED6-18779D392EBC wds:Q73016380-D6BD4BF8-B5DF-4B89-A88F-928153C7A73E wds:Q73016380-EDEFEB8F-43EF-468F-9178-483999C02642 wds:Q73016380-F1520460-DCA3-4C2B-820C-FEAF07F94BC9 wds:Q73016380-FDEFDA1B-5075-41CB-9415-FE916A956512
cites work	Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome Nonparametric Estimation from Incomplete Observations Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer Ethanolamine sclerotherapy of a renal cyst Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Potential benefit of improved local tumor control in patients with prostate carcinoma Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. The effect of pelvic radiation therapy on serum levels of prostate specific antigen Prostate-specific antigen and radiation therapy for clinically localized prostate cancer Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer Current Status of Prostate-Specific Antigen in the Radiotherapeutic Management of Prostatic Cancer A pathologist's view of prostatic carcinoma Local Control After Radiation for Prostatic Carcinoma: Significance and Assessment
author name string	wds:Q73016380-3C20AED6-758B-4108-A85C-186BA2E40FB0 wds:Q73016380-53EE8681-B739-41F4-9A69-1865B4C31156 wds:Q73016380-79FB8549-79B0-41F1-8010-8489CCD51CEE wds:Q73016380-9FCCA798-8AC8-4B0C-A725-59BE077DE49E wds:Q73016380-BD967CD8-719C-49EE-8845-0F5042AE4D7D wds:Q73016380-D46455AF-B05F-40D1-BCF7-6E411AB07421
author name string	G A Perry J M Crook R G Bociek S J Robertson B A Esche Y A Bahadur
rdfs:label	Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (en) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (nl) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (sq)
skos:prefLabel	Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (en) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (nl) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (sq)
name	Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (en) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (nl) Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (sq)
title	wds:Q73016380-82DD433F-6F49-4AEF-B0F8-049F0B1C070E
title	Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen (en)
page(s)	wds:Q73016380-EFBAF852-1085-4777-9879-91953ED2071E
page(s)	328-336
instance of	wds:Q73016380-1F54A879-388F-4883-981A-EFFF700585C7
instance of	scholarly article
PubMed ID	wds:Q73016380-9F209907-F7CD-4F41-AA61-2BCDD2BB1F47
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9010106
PubMed ID	9010106
published in	wds:Q73016380-6ED4440F-3E46-4FA3-826A-81FD41F916EC
published in	Cancer
issue	wds:Q73016380-F3F370F2-29BD-4B49-8ADA-FD9CD47974CB
volume	wds:Q73016380-75D162A0-E24D-42F9-839E-7E2E3B72A642
issue	2
volume	79
DOI	wds:Q73016380-34436A6E-7545-4307-991B-1CC68A338680
DOI	http://dx.doi.org/10.1002/(SICI)1097-0142(19970115)79:2%3C328::AID-CNCR16%3E3.0.CO;2-2
DOI	10.1002/(SICI)1097-0142(19970115)79:2<328::AID-CNCR16>3.0.CO;2-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73016380
is cites work of	The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques Treatment options for early prostate cancer Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial Radiation therapy failure in prostate cancer patients: risk factors and methods of detection. Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer. Conformal proton therapy for early-stage prostate cancer Prostate cancer gene therapy clinical trials

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software